UK guidelines for the management of pituitary apoplexy
| Autor: | Andrew Markey, Marian Lanyon, Mark Vanderpump, Narenda Lakshmana Reddy, Gordon T. Plant, Michael Powell, John A.H. Wass, W. M. Drake, Senthil Rajasekaran, Saurabh Sinha, Stephanie E Baldeweg |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
medicine.medical_specialty
Pituitary gland business.industry Endocrinology Diabetes and Metabolism Visual impairment Pituitary apoplexy Infarction medicine.disease Endocrinology medicine.anatomical_structure Internal medicine medicine Vomiting Neurosurgery medicine.symptom business Abducens nerve Hydrocortisone medicine.drug |
| Zdroj: | Clinical Endocrinology. 74:9-20 |
| ISSN: | 0300-0664 |
| Popis: | Classical pituitary apoplexy is a medical emergency and rapid replacement with hydrocortisone maybe life saving. It is a clinical syndrome characterized by the sudden onset of headache, vomiting, visual impairment and decreased consciousness caused by haemorrhage and/or infarction of the pituitary gland. It is associated with the sudden onset of headache accompanied or not by neurological symptoms involving the second, third, fourth and sixth cranial nerves. If diagnosed patients should be referred to a multidisciplinary team comprising, amongst others, a neurosurgeon and an endocrinologist. Apart from patients with worsening neurological symptoms in whom surgery is indicated, it is unclear currently for the majority of patients whether conservative or surgical management carries the best outcome. Post apoplexy, there needs to be careful monitoring for recurrence of tumour growth. It is suggested that further trials be carried out into the management of pituitary apoplexy to optimize treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text